Bayer Pink Sheet Today

BAYRY
 Stock
  

USD 13.93  0.07  0.51%   

Market Performance
1 of 100
Odds Of Distress
Less than 10
Bayer AG is trading at 13.93 as of the 9th of December 2022; that is 0.51 percent up since the beginning of the trading day. The stock's open price was 13.86. Bayer AG has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Bayer AG PK are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of December 2020 and ending today, the 9th of December 2022. Click here to learn more.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States. The company has 3.93 B outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. More on Bayer AG PK

Moving together with Bayer AG

+0.89PFEPfizer Inc Aggressive PushPairCorr
+0.83JPMJPMorgan Chase Fiscal Year End 13th of January 2023 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bayer AG Pink Sheet Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bayer AG's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bayer AG or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOLiam Condon
Average Analyst Recommendation
Analysts covering Bayer AG report their recommendations after researching Bayer AG's financial statements, talking to executives and customers, or listening in on Bayer AG's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bayer AG PK. The Bayer consensus assessment is calculated by taking the average forecast from all of the analysts covering Bayer AG.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bayer AG's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldUndervalued
Bayer AG PK [BAYRY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 57.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bayer AG's market, we take the total number of its shares issued and multiply it by Bayer AG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bayer AG PK classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 3.93 B outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. Bayer AG PK has accumulated about 9.07 B in cash with 5.09 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31.
Check Bayer AG Probability Of Bankruptcy

Bayer Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Bayer AG jumping above the current price in 90 days from now is about 14.31%. The Bayer AG PK probability density function shows the probability of Bayer AG pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Bayer AG has a beta of 0.0936 suggesting as returns on the market go up, Bayer AG average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bayer AG PK will be expected to be much smaller as well. Additionally, the company has an alpha of 0.146, implying that it can generate a 0.15 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 13.93HorizonTargetOdds Above 13.93
85.58%90 days
 13.93 
14.31%
Based on a normal probability distribution, the odds of Bayer AG to move above the current price in 90 days from now is about 14.31 (This Bayer AG PK probability density function shows the probability of Bayer Pink Sheet to fall within a particular range of prices over 90 days) .

Bayer AG PK Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bayer AG market risk premium is the additional return an investor will receive from holding Bayer AG long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bayer AG. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bayer AG's alpha and beta are two of the key measurements used to evaluate Bayer AG's performance over the market, the standard measures of volatility play an important role as well.

Bayer Stock Against Markets

Picking the right benchmark for Bayer AG pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bayer AG pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bayer AG is critical whether you are bullish or bearish towards Bayer AG PK at a given time.
The entity Bayer AG PK with a symbol BAYRY was recently relisted or delisted. You can potentially use Bayer AG PK with a symbol BAYRY. Please make sure the ticker renaming or change in the classification of Bayer AG PK is not a temporary action by the exchange.

Bayer AG Corporate Management

Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oliver Maier - Head RelationsProfile
Heiko Schipper - Member of the Management Board, Head of the Consumer Health DivisionProfile
Thomas Fischer - Member of the Supervisory BoardProfile
Helmut Panke - Member of the Supervisory BoardProfile
Reiner Hoffmann - Member of the Supervisory BoardProfile
Sue Rataj - Member of the Supervisory BoardProfile

Invested in Bayer AG PK?

The danger of trading Bayer AG PK is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bayer AG is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bayer AG. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bayer AG PK is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for analysis

When running Bayer AG PK price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Please note, there is a significant difference between Bayer AG's value and its price as these two are different measures arrived at by different means. Investors typically determine Bayer AG value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bayer AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.